IBD Symposium

Second Annual Medical and Interventional IBD Symposium

July 28, 2023 · Hybrid

7:30 AM - 4:30 PM (ET)

Program Overview

Inflammatory bowel diseases (IBD) consist of two primary phenotypes, Crohn’s disease (CD) and ulcerative colitis (UC). Management of IBD involves a multidisciplinary approach, with medical, endoscopic, and surgical aspects. The main venues of the symposium will include lectures on recent advances in the medical therapy of IBD, the prevention of infectious complications, pre- and post-operative prophylaxis, disease monitoring, and endoscopic management of disease- and surgery- complications. The audience will enjoy lectures and interacting with the leading experts in the field. This is a joint venture of Columbia University Irving Medical Center, NewYork Presbyterian Hospital, Orlando Health, FL, and the Global Interventional IBD Group.

Learning Objectives:

• To be familiar with the current status of biological therapy in IBD

• To be familiar with principles, indications, techniques, and outcomes of endoscopic therapy for strictures, fistulae, and surgical leaks in IBD

• To be familiar with principles, diagnosis, and management of colitis-associated neoplasia in IBD

• To be familiar with rescue strategies for endoscopy-associated complications

Target Audience

This program has been designed for regional, national, and worldwide audiences, including gastroenterologists, inflammatory bowel disease specialists, GI endoscopists, colorectal surgeons, general surgeons, GI pathologists, GI radiologists, NP/PA/RN in gastroenterology, IBD, and colorectal surgery, stoma nurses, medical students, medical/surgical residents, and GI/colorectal fellows.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

PHYSICIANS

Amedco LLC designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 6.50 AMA PRA Category 1 Credits™ for completing this activity.

NURSE PRACTITIONERS

The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Refund Policy

Registration is limited and will be handled on a first-come, first-served basis. Telephone registrations/cancellations/refunds cannot be accepted.

Method of Participation

You will receive a confirmation email before the event with instructions for joining via Zoom.

Registration Fees

Registration Options

All Healthcare Professionals: Free

Agenda

Friday, July 28

7:30 AM - 8:50 AM

Breakfast & Registration

8:50 AM - 9:00 AM

Welcome Remarks

9:00 AM

SESSION I: MEDICAL THERAPY WITH ANTI-TNF

9:00 AM - 9:20 AM

Update of Anti-TNF Therapy in Crohn’s Disease

9:20 AM - 9:40 AM

Update of Anti-TNF Therapy in Ulcerative Colitis

9:40 AM - 10:00 AM

Update of Vaccination in IBD Patients

10:00 AM - 10:20 AM

Pre- and Post- Operative Medical Management of CD and UC

10:20 AM - 10:30 AM

Q & A

10:30 AM - 10:40 AM

Exhibitor Hall & Break

10:40 AM

SESSION II: MEDICAL THERAPY WITH ANTI-INTEGRIN, ANTI-IL, SMALL MOLECULES, AND IMMUNOMODULATORS

10:40 AM - 11:00 AM

Update of Anti-integrin Therapy in IBD

11:00 AM - 11:20 AM

Update of Anti-IL in IBD

11:20 AM - 11:40 AM

Update of Small Molecules in IBD

11:40 AM - 12:00 PM

Role of Immunomodulators in the Current “Biological Era."

12:00 PM - 12:10 PM

Q&A

12:10 PM - 1:10 PM

Lunch and Satellite Symposium

1:10 PM

SESSION III: ENDOSCOPY, SURGERY, AND CASE DISCUSSION

1:10 PM - 1:30 PM

Overview of Surgery in CD and UC

1:30 PM - 1:50 PM

Endoscopic Therapy of IBD Strictures

1:50 PM - 2:50 PM

VIDEO SESSIONS

Video 1: Endoscopic evaluation of disease activity in CD and UC Video 2: Endoscopic Evaluation of Postoperative CD Video 3: Endoscopic Evaluation of Postoperative UC Video 4: Endoscopic Stricture Dilation Video 5: Endoscopic Stricturotomy

2:50 PM - 3:00 PM

Q&A

3:00 PM - 4:20 PM

Case Discussions-“The IBD BOARD”(click to review)

4:20 PM - 4:30 PM

Closing Remarks

Faculty